- Home
- NMM vs OCUL Comparison
NMM vs OCUL Comparison
Compare NMM & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMM | OCUL |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2007 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NMM | OCUL |
|---|---|---|
| Price | $77.71 | $8.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | ★ $85.00 | $23.56 |
| AVG Volume (30 Days) | 96.7K | ★ 2.0M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.34% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $5.57 | $7.93 |
| Revenue Next Year | $3.66 | $96.07 |
| P/E Ratio | $7.24 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $40.80 | $6.23 |
| 52 Week High | $80.97 | $16.44 |
Technical Indicators
Market Signals| Indicator | NMM | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 58.38 | 41.25 |
| Support Level | $69.21 | $7.77 |
| Resistance Level | $80.69 | $9.93 |
| Average True Range (ATR) | 2.39 | 0.49 |
| MACD | 0.38 | -0.16 |
| Stochastic Oscillator | 62.05 | 12.98 |
Price Performance
Historical ComparisonAbout NMM Navios Maritime Partners LP
Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.